Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro

Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro

Little is known about the interaction of novel anticancer drugs with other treatment modalities. The aim of this study was to examine the effect of combining imatinib mesylate (STI-571) with radiation or cisplatin on the survival of two human solid tumor cell lines – SKNMC cells derived from Ewing s...

Full description

Saved in:
Bibliographic Details
Date:2007
Main Authors: Yerushalmi, R., Nordenberg, J., Beery, E., Uziel, O., Lahav, M., Luria, D., Fenig, E.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2007
Series:Experimental Oncology
Subjects:
Original contributions
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/138577
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro / R. Yerushalmi, J. Nordenberg, E. Beery, O. Uziel, M. Lahav, D. Luria, E. Fenig // Experimental Oncology. — 2007. — Т. 29, № 2. — С. 126–131. — Бібліогр.: 29 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Similar Items

Similar Items